	ID	Description	GeneRatio	BgRatio	pvalue	geneID	Count
WP143	WP143	Fatty acid beta-oxidation	4/78	34/8701	0.00022596387362385	37/38/1892/2639	4
WP5037	WP5037	Riboflavin and CoQ disorders	3/78	14/8701	0.000234964023668069	2110/80308/57107	3
WP5172	WP5172	Iron metabolism disorders	3/78	17/8701	0.000430517748046234	617/2495/2512	3
WP4686	WP4686	Leucine, isoleucine and valine metabolism	3/78	24/8701	0.00122485881563226	38/4329/1892	3
WP3998	WP3998	Prader-Willi and Angelman syndrome	5/78	111/8701	0.00311112953349742	8086/23225/348995/79902/5108	5
WP465	WP465	Tryptophan metabolism	3/78	33/8701	0.00311612184307898	38/1892/2639	3
WP5345	WP5345	1p36 copy number variation syndrome	5/78	112/8701	0.00323402615143012	55210/55174/55052/26155/11079	5
WP4190	WP4190	Mevalonate arm of cholesterol biosynthesis pathway	2/78	13/8701	0.00580465507204897	38/2222	2
WP4705	WP4705	Pathways of nucleic acid metabolism and innate immune sensing	2/78	16/8701	0.0087763130398095	10535/8635	2
WP5153	WP5153	N-glycan biosynthesis	3/78	57/8701	0.0143350964776638	79053/79796/3703	3
WP4288	WP4288	MTHFR deficiency	2/78	24/8701	0.0192742846686901	1312/1788	2
WP5276	WP5276	Estrogen metabolism	2/78	24/8701	0.0192742846686901	1312/7923	2
WP4313	WP4313	Ferroptosis	3/78	65/8701	0.0203395942353236	2222/2495/2512	3
WP4521	WP4521	Glycosylation and related congenital defects	2/78	25/8701	0.0208300529091874	79053/79796	2
WP5183	WP5183	SARS-CoV-2 mitochondrial chronic oxidative stress and endothelial dysfunction	2/78	27/8701	0.0240924642081731	28976/617	2
WP5038	WP5038	Mitochondrial immune response to SARS-CoV-2	2/78	33/8701	0.0350158110781007	28976/617	2
WP5355	WP5355	Metabolic Epileptic Disorders	3/78	91/8701	0.0480133706492059	38/1892/2639	3
WP5323	WP5323	Fatty Acids and Lipoproteins Transport in Hepatocytes	7/78	382/8701	0.0545893046326324	215/38/1892/2222/27349/54940/9522	7
WP5329	WP5329	Cholesterol biosynthesis pathway in hepatocytes	3/78	111/8701	0.0773716795122016	2222/51170/7923	3
WP4220	WP4220	Neurotransmitter disorders	1/78	10/8701	0.0861564679086975	1312	1
WP4846	WP4846	SARS-CoV-2 and COVID-19 pathway	1/78	10/8701	0.0861564679086975	38	1
WP4324	WP4324	Mitochondrial complex I assembly model OXPHOS system	2/78	56/8701	0.0896289432745089	28976/4713	2
WP4788	WP4788	Autosomal recessive osteopetrosis pathways	1/78	11/8701	0.0943580322284677	1186	1
WP5120	WP5120	Inclusion body myositis	1/78	11/8701	0.0943580322284677	23385	1
WP5233	WP5233	Arsenic metabolism and reactive oxygen species generation	1/78	11/8701	0.0943580322284677	28958	1
WP2007	WP2007	Iron metabolism in placenta	1/78	12/8701	0.102486924459328	2495	1
WP2513	WP2513	Nanoparticle triggered regulated necrosis	1/78	12/8701	0.102486924459328	2512	1
WP2436	WP2436	Dopamine metabolism	1/78	13/8701	0.110543780241601	1312	1
WP4271	WP4271	Vitamin B12 disorders	1/78	13/8701	0.110543780241601	326625	1
WP4657	WP4657	22q11.2 copy number variation syndrome	3/78	130/8701	0.110942471801032	1312/64976/1104	3
WP197	WP197	Cholesterol biosynthesis pathway	1/78	15/8701	0.126443897632283	2222	1
WP4156	WP4156	Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine	1/78	15/8701	0.126443897632283	1312	1
WP5152	WP5152	Iron-sulfur cluster biogenesis	1/78	15/8701	0.126443897632283	3313	1
WP550	WP550	Biogenic amine synthesis	1/78	15/8701	0.126443897632283	1312	1
WP2291	WP2291	Deregulation of Rab and Rab effector genes in bladder cancer	1/78	16/8701	0.134288403271782	84958	1
WP3644	WP3644	NAD+ metabolism	1/78	16/8701	0.134288403271782	64802	1
WP4210	WP4210	Tryptophan catabolism leading to NAD+ production	1/78	16/8701	0.134288403271782	64802	1
WP4921	WP4921	Mitochondrial complex III assembly	1/78	16/8701	0.134288403271782	617	1
WP368	WP368	Mitochondrial long chain fatty acid beta-oxidation	1/78	17/8701	0.142063360617182	37	1
WP4815	WP4815	Glycosaminoglycan degradation	1/78	17/8701	0.142063360617182	138050	1
WP4656	WP4656	Joubert syndrome	2/78	76/8701	0.148332049917259	402/5108	2
WP4936	WP4936	Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins	1/78	18/8701	0.149769378336189	8673	1
WP5193	WP5193	Cholesterol synthesis disorders	1/78	18/8701	0.149769378336189	2222	1
WP697	WP697	Estrogen metabolism	1/78	18/8701	0.149769378336189	1312	1
WP5123	WP5123	Mitochondrial fatty acid oxidation disorders	1/78	19/8701	0.1574070598391	37	1
WP4225	WP4225	Pyrimidine metabolism and related diseases	1/78	20/8701	0.164977003323614	4329	1
WP5331	WP5331	Autophagy in pancreatic ductal adenocarcinoma	1/78	20/8701	0.164977003323614	10526	1
WP3657	WP3657	Hematopoietic stem cell gene regulation by GABP alpha/beta complex	1/78	21/8701	0.172479801819266	1788	1
WP4884	WP4884	Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex	1/78	21/8701	0.172479801819266	55922	1
WP4022	WP4022	Pyrimidine metabolism	2/78	84/8701	0.173583277156211	4832/87178	2
WP357	WP357	Fatty acid biosynthesis	1/78	22/8701	0.17991604323149	1892	1
WP3645	WP3645	NAD+ biosynthetic pathways	1/78	22/8701	0.17991604323149	64802	1
WP4357	WP4357	NRF2-ARE regulation	1/78	23/8701	0.187286310385303	192111	1
WP325	WP325	Triacylglyceride synthesis	1/78	24/8701	0.194591181068634	55326	1
WP5316	WP5316	Primary ovarian insufficiency	3/78	174/8701	0.20462260164795	1312/10456/56945	3
WP3613	WP3613	Photodynamic therapy-induced unfolded protein response	1/78	27/8701	0.216119117518235	7184	1
WP241	WP241	One-carbon metabolism	1/78	29/8701	0.230154462791589	1788	1
WP430	WP430	Statin inhibition of cholesterol production	1/78	31/8701	0.243941670755772	2222	1
WP4932	WP4932	7q11.23 copy number variation syndrome	2/78	106/8701	0.245718455485181	10514/26608	2
WP3995	WP3995	Prion disease pathway	1/78	32/8701	0.250743579600184	7184	1
WP5365	WP5365	4p16.3 copy number variation	1/78	32/8701	0.250743579600184	617	1
WP4786	WP4786	Type I collagen synthesis in the context of osteogenesis imperfecta	1/78	33/8701	0.257485072366499	79709	1
WP4950	WP4950	16p11.2 distal deletion syndrome	1/78	33/8701	0.257485072366499	7284	1
WP4922	WP4922	Mitochondrial complex IV assembly	1/78	34/8701	0.264166678775753	28958	1
WP5333	WP5333	Enterocyte cholesterol metabolism	1/78	36/8701	0.277352328526622	2222	1
WP1433	WP1433	Nucleotide-binding oligomerization domain (NOD) pathway	1/78	41/8701	0.309304649375789	64170	1
WP5093	WP5093	Opioid receptor pathways	1/78	41/8701	0.309304649375789	1788	1
WP4577	WP4577	Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway	1/78	44/8701	0.327802304150554	2512	1
WP268	WP268	Notch signaling	1/78	45/8701	0.333858838778746	23385	1
WP4758	WP4758	Nephrotic syndrome	1/78	45/8701	0.333858838778746	57107	1
WP4718	WP4718	Cholesterol metabolism with Bloch and Kandutsch-Russell pathways	1/78	47/8701	0.345810752255557	2222	1
WP1541	WP1541	Energy metabolism	1/78	48/8701	0.351707073185077	10514	1
WP2884	WP2884	NRF2 pathway	2/78	141/8701	0.361535996044574	2495/2512	2
WP1533	WP1533	Vitamin B12 metabolism	1/78	51/8701	0.369083059856827	326625	1
WP5346	WP5346	8p23.1 copy number variation syndrome	1/78	54/8701	0.385999136003298	2222	1
WP623	WP623	Oxidative phosphorylation	1/78	60/8701	0.418499322799038	4713	1
WP5352	WP5352	10q11.21q11.23 copy number variation syndrome	1/78	61/8701	0.423748374161343	10514	1
WP61	WP61	Notch signaling pathway	1/78	61/8701	0.423748374161343	23385	1
WP5180	WP5180	DYRK1A involvement regarding cell proliferation in brain development	1/78	62/8701	0.428950645783498	23385	1
WP3624	WP3624	Lung fibrosis	1/78	64/8701	0.439216492378513	5073	1
WP3651	WP3651	Pathways affected in adenoid cystic carcinoma	1/78	65/8701	0.444280879734595	29128	1
WP2525	WP2525	Trans-sulfuration, one-carbon metabolism and related pathways	1/78	68/8701	0.459204698578061	1788	1
WP176	WP176	Folate metabolism	1/78	69/8701	0.464090837059575	80308	1
WP1982	WP1982	Sterol regulatory element-binding proteins (SREBP) signaling	1/78	71/8701	0.473732740403013	2222	1
WP2359	WP2359	Parkin-ubiquitin proteasomal system pathway	1/78	71/8701	0.473732740403013	3313	1
WP5304	WP5304	Cholesterol metabolism	1/78	72/8701	0.478489269516404	2222	1
WP5356	WP5356	Disturbed pathways in Duchenne Muscular Dystrophy	1/78	74/8701	0.487875368411074	3313	1
WP702	WP702	Metapathway biotransformation Phase I and II	2/78	185/8701	0.496886345778829	1312/55226	2
WP5205	WP5205	Clock-controlled autophagy in bone metabolism	1/78	80/8701	0.515044503233826	10131	1
WP15	WP15	Selenium micronutrient network	1/78	86/8701	0.54078977294306	80308	1
WP477	WP477	Cytoplasmic ribosomal proteins	1/78	88/8701	0.549067964125196	9801	1
WP231	WP231	TNF-alpha signaling pathway	1/78	92/8701	0.565184879956467	10131	1
WP4352	WP4352	Ciliary landscape	2/78	215/8701	0.578386462174246	1892/10128	2
WP5287	WP5287	17q12 copy number variation syndrome	1/78	101/8701	0.59939798516064	8148	1
WP111	WP111	Electron transport chain: OXPHOS system in mitochondria	1/78	105/8701	0.61373739088232	4713	1
WP5366	WP5366	NF1 copy number variation syndrome 	1/78	110/8701	0.630950869637894	55813	1
WP5380	WP5380	5q35 copy number variation	1/78	111/8701	0.634301565967569	51428	1
WP5322	WP5322	CKAP4 signaling pathway map	1/78	116/8701	0.650609798110688	7818	1
WP179	WP179	Cell cycle	1/78	120/8701	0.663137652215463	51434	1
WP2858	WP2858	Ectoderm differentiation	1/78	142/8701	0.724514248638932	11177	1
WP2853	WP2853	Endoderm differentiation	1/78	145/8701	0.731978365437241	10128	1
WP4396	WP4396	Nonalcoholic fatty liver disease	1/78	155/8701	0.75544576710809	4713	1
WP706	WP706	Sudden infant death syndrome (SIDS) susceptibility pathways	1/78	160/8701	0.766406740916686	7184	1
WP2882	WP2882	Nuclear receptors meta-pathway	2/78	314/8701	0.778396592333066	2495/2512	2
WP2877	WP2877	Vitamin D receptor pathway	1/78	187/8701	0.81772916569239	215	1
WP3594	WP3594	Circadian rhythm genes	1/78	201/8701	0.839780574569024	10514	1
WP5115	WP5115	Network map of SARS-CoV-2 signaling pathway	1/78	218/8701	0.863041804828564	55922	1
WP5124	WP5124	Alzheimer's disease	1/78	263/8701	0.909720884866589	23385	1
WP5413	WP5413	IL-24 Signaling pathway	1/78	291/8701	0.930421581145664	7184	1
WP3932	WP3932	Focal adhesion: PI3K-Akt-mTOR-signaling pathway	1/78	302/8701	0.937203727601806	7184	1
WP2059	WP2059	Alzheimer's disease and miRNA effects	1/78	328/8701	0.950748158339775	23385	1
WP4172	WP4172	PI3K-Akt signaling pathway	1/78	339/8701	0.95556922205462	7184	1
WP3888	WP3888	VEGFA-VEGFR2 signaling	1/78	432/8701	0.981504781741517	26058	1
WP5087	WP5087	Pleural mesothelioma	1/78	440/8701	0.982855812002876	29128	1
